WallStreetZenWallStreetZen

NYSEMKT: MTNB
Matinas Biopharma Holdings Inc Earnings & Revenue

MTNB past revenue growth

How has MTNB's revenue growth performed historically?
Company
-100%
Industry
90.19%
Market
19.07%
MTNB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MTNB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MTNB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$23.3M
Current Profit Margin
0%

MTNB Return on Equity

Current Company
-109.7%
Current Industry
16.8%
Current Market
28.2%
MTNB's Return on Equity (-109.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MTNB announces earnings.

MTNB Return on Assets

Current Company
-85.7%
Current Industry
3.2%
MTNB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MTNB Return on Capital Employed

Current Company
-132.03%
Current Industry
-42.4%
MTNB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MTNB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MTNB$0.00-$22.30M-$23.25M-100.00%N/A
MRKR$3.32M-$6.63M-$5.66M+74.37%N/A
CALC$0.00-$14.88M-$14.94MN/AN/A
ELTX$0.00-$36.83M-$38.99M-100.00%N/A
LSBN/AN/AN/AN/AN/A

MTNB earnings dates

Next earnings date
Aug 7, 2024

Matinas Biopharma Holdings Earnings & Revenue FAQ

What were MTNB's earnings last quarter?

On Invalid Date, Matinas Biopharma Holdings (NYSEMKT: MTNB) reported Q1 2024 earnings per share (EPS) of -$0.03, up 0% year over year. Total Matinas Biopharma Holdings earnings for the quarter were -$5.82 million. In the same quarter last year, Matinas Biopharma Holdings's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Matinas Biopharma Holdings stock.

What was MTNB's earnings growth in the past year?

As of Q3 2024, Matinas Biopharma Holdings's earnings has grown year over year. Matinas Biopharma Holdings's earnings in the past year totalled -$23.25 million.

What is MTNB's earnings date?

Matinas Biopharma Holdings's earnings date is Invalid Date. Add MTNB to your watchlist to be reminded of MTNB's next earnings announcement.

What was MTNB's revenue last quarter?

On Invalid Date, Matinas Biopharma Holdings (NYSEMKT: MTNB) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Matinas Biopharma Holdings's revenue was $1.10 million.

What was MTNB's revenue growth in the past year?

As of Q3 2024, Matinas Biopharma Holdings's revenue has grown -100% year over year. This is 190.19 percentage points lower than the US Biotechnology industry revenue growth rate of 90.19%. Matinas Biopharma Holdings's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.